Boston's thrombi removal system:
This article was originally published in Clinica
The US FDA has given Boston Scientific 510(k) clearance to sell its Rio aspiration catheter for removing thrombi from arteries. The device is comprised of two tubular cavities. The primary lumen is used to extract the thrombus. It is open at one end and attached via an extension tube to a 20cc locking syringe on the other. The syringe is used to apply suction and aspirate the thrombus from the vessel. The second lumen accommodates a guide wire, which is used to move the catheter into position within the target artery.
You may also be interested in...
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.
Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.
The COVID-19 pandemic has triggered extraordinary levels of collaboration. But competition remains, and many newly created coalitions have yet to be stress tested.